Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy
Primary Purpose
Cholecystolithiasis
Status
Unknown status
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
Gabapentin
S-ketamine
Lidocaine
Droperidol
Sponsored by
About this trial
This is an interventional treatment trial for Cholecystolithiasis
Eligibility Criteria
Inclusion Criteria: Elective laparoscopic cholecystectomy Age above 18 years Written informed consent ASA class I-III Exclusion Criteria: Planned abdominal cholecystectomy Intraoperative conversion of laparoscopic to laparotomic cholecystectomy Allergy to part of the treatment regimens Previous reactions to opioids (nausea, cognition)
Sites / Locations
- Dept of Anaesthesia, Hvidovre Hospital
Outcomes
Primary Outcome Measures
1. postoperative abilities over time in PACU
2. discharge time from PACU according to fixed criteria
3. consumption of analgesics and antiemetics in the PACU
Secondary Outcome Measures
1. Degree of nursing requirements in the PACU
2. General tolerability of the regimens
Full Information
NCT ID
NCT00209885
First Posted
September 14, 2005
Last Updated
September 14, 2005
Sponsor
Hvidovre University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT00209885
Brief Title
Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy
Study Type
Interventional
2. Study Status
Record Verification Date
September 2005
Overall Recruitment Status
Unknown status
Study Start Date
October 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Hvidovre University Hospital
4. Oversight
5. Study Description
Brief Summary
To test the current standard of care (SOC) treatment for laparoscopic cholecystectomy with a group receiving SOC + additional perioperative analgesics in terms of postoperative abilities, PONV, pain and discharge time from the PACU
Detailed Description
Aim of the study: to compare postoperative complaints (PONV, pain, etc) and PACU discharge time between two groups:
A: standard of care (SOC)receiving intraoperative dexamethasone, ondansetron, ketorolac, and general anaesthesia with propofol, remifentanil and cisatracurium
B: SOC + preoperative gabapentin, intraoperative lidocain infusion, s-ketamin and droperidol.
Primary endpoints:
postoperative abilities over time
discharge time from PACU according to fixed criteria
consumption of analgesics and antiemetics in the PACU
Secondary endpoints:
degree of nursing requirements at the PACU
General tolerability of the regimes
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cholecystolithiasis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
60 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Gabapentin
Intervention Type
Drug
Intervention Name(s)
S-ketamine
Intervention Type
Drug
Intervention Name(s)
Lidocaine
Intervention Type
Drug
Intervention Name(s)
Droperidol
Primary Outcome Measure Information:
Title
1. postoperative abilities over time in PACU
Title
2. discharge time from PACU according to fixed criteria
Title
3. consumption of analgesics and antiemetics in the PACU
Secondary Outcome Measure Information:
Title
1. Degree of nursing requirements in the PACU
Title
2. General tolerability of the regimens
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Elective laparoscopic cholecystectomy
Age above 18 years
Written informed consent
ASA class I-III
Exclusion Criteria:
Planned abdominal cholecystectomy
Intraoperative conversion of laparoscopic to laparotomic cholecystectomy
Allergy to part of the treatment regimens
Previous reactions to opioids (nausea, cognition)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kenneth Jensen, M.D.
Phone
+45 36 32 62 90
Email
kenneth.jensen@hh.hosp.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kenneth Jensen, M.D.
Organizational Affiliation
Dept of Anaesthesia, Acute Pain Service, Hvidovre Hospital, Copenhagen, Denmark
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Claus Lund, dr.med.sci
Organizational Affiliation
Dept of Anaesthesia, Hvidovre Hospital, Copenhagen, Denmark
Official's Role
Study Chair
Facility Information:
Facility Name
Dept of Anaesthesia, Hvidovre Hospital
City
Copenhagen
State/Province
Hvidovre
ZIP/Postal Code
2650
Country
Denmark
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kenneth Jensen, M.D.
Phone
+45 36 32 62 90
Email
kenneth.jensen@hh.hosp.dk
First Name & Middle Initial & Last Name & Degree
Kenneth Jensen, M.D.
12. IPD Sharing Statement
Links:
URL
http://www.postoppain.org
Description
URL looking into anaesthesia and surgery for cholecystectomy
Learn more about this trial
Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy
We'll reach out to this number within 24 hrs